Virtu Financial’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Virtu Financial’s Portfolio UBIO Stock Details UBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,328	Closed	-$244K	–	2058
2019 Q1	$244K	Sell	8,328 -3,683	-31%	-$105K	0.01%	895
2018 Q4	$240K	Sell	12,011 -9,743	-45%	-$276K	0.01%	843
2018 Q3	$961K	Sell	21,754 -13,593	-38%	-$549K	0.06%	349
2018 Q2	$1.18M	Buy	35,347 +12,703	+56%	+$396K	0.07%	318
2018 Q1	$721K	Buy	+22,644	New	+$832K	0.04%	512
2017 Q2	–	Sell	-12,843	Closed	-$355K	–	546
2017 Q1	$355K	Buy	+12,843	New	+$338K	0.04%	276
2016 Q4	–	Sell	-14,846	Closed	-$429K	–	604
2016 Q3	$429K	Sell	14,846 -77,824	-84%	-$2.22M	0.07%	229
2016 Q2	$1.97M	Buy	92,670 +29,800	+47%	+$755K	0.26%	78
2016 Q1	$1.49M	Buy	62,870 +37,425	+147%	+$1.03M	0.21%	113
2015 Q4	$1.47M	Buy	+25,445	New	+$1.35M	0.21%	99

Other funds holding UBIO

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Virtu Financial's UBIO Position: Q2 2019 in Review

Virtu Financial sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q2 2019, closing a stake of 8,328 shares — an estimated $244K sold.

Virtu Financial first reported a position in UBIO in Q4 2015 and held it in 10 quarters. The position peaked at $1.97M in Q2 2016. 6 funds tracked by Wall St. Rank hold UBIO as of Q2 2019.

Virtu Financial reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q2 2019 after selling out during the quarter.
Virtu Financial sold 8,328 Proshares UltraPro NASDAQ Biotechnology shares in Q2 2019, an estimated $244K.
Virtu Financial first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 10 quarters.
Virtu Financial's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.97M in Q2 2016.
6 funds tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.